Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15927738 | 1.00 | ADRA2C (0.59) | ADRA2CKCNH2LMNAPKMTDP1 | |
| Nitric Acid SCHEMBL10833077 | 0.91 | ADRA2C (0.51) | ADRA2CKCNH2LMNAPKMTDP1 | |
| SCHEMBL10959036 | 0.89 | ADRA2C (0.46) | ADRA2CLMNAPKMTDP1MEN1 | |
| SCHEMBL10961074 | 0.86 | POLB (0.51) | ADRA2CLMNAPKMTDP1MEN1 | |
| SCHEMBL31254073 | 0.86 | ADRA2C (0.50) | ADRA2CKCNH2LMNAPKMTDP1 | |
| SCHEMBL9785351 | 0.86 | ADRA2C (0.45) | ADRA2CLMNAPKMMEN1KMT2A | |
| SCHEMBL29622918 | 0.86 | ADRA2C (0.45) | ADRA2CLMNAPKMMEN1KMT2A | |
| SCHEMBL10978037 | 0.85 | CYP19A1 (0.46) | ADRA2CKCNH2LMNAPKMTDP1 | |
| SCHEMBL11018513 | 0.85 | ADRA2C (0.45) | ADRA2CKCNH2LMNAPKMTDP1 | |
| SCHEMBL11182405 | 0.85 | ADRA2C (0.40) | ADRA2CMEN1KMT2ACYP19A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113954192-A | Wood preservative formulation | 拱木保护有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113717950-A | Hybridoma cell strain secreting penconazole monoclonal antibody and application thereof | 江南大学 | 2021-11-30 | — | — | CN | claimed |
| WO-2013090995-A1 | A WOOD PRESERVATIVE | ARCH WOOD PROTECTION PTY LTD (AU) | 2013-06-27 | — | — | WO | claimed |
| CN-102295610-B | Preparation method and application of 1-aryl-2-(1,2,4-triazole-1-group) ethanol | UNIV HUNAN | 2013-01-23 | — | — | CN | claimed |
| CN-113717950-B | Hybridoma cell strain secreting penconazole monoclonal antibody and application thereof | 江南大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-113954192-A | Wood preservative formulation | 拱木保护有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113717950-A | Hybridoma cell strain secreting penconazole monoclonal antibody and application thereof | 江南大学 | 2021-11-30 | — | — | CN | disclosed |
| CN-108289454-B | Microorganism control agent and miticidal composition | 大阪燃气化学株式会社 | 2021-11-09 | — | — | CN | disclosed |
| US-11028078-B2 | Itraconazole analogs and use thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2021-06-08 | — | — | US | disclosed |
| US-20190040046-A1 | ITRACONAZOLE ANALOGS AND USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-02-07 | — | — | US | disclosed |
| US-9844220-B2 | Synergistic fungicidal active substance combinations | FMC CORPORATION (US) | 2017-12-19 | — | — | US | disclosed |
| US-9717247-B2 | Synergistic fungicidal active combinations | BAYER CROPSCIENCE AG (DE) | 2017-08-01 | — | — | US | disclosed |
| US-4327104-A | FUNGICIDES AND BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-27 | — | — | US | disclosed |
| EP-0000017-B1 | 1-(2-PHENYLETHYL)-TRIAZOLIUM SALTS, THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1981-09-30 | — | — | EP | disclosed |
| US-4256754-A | PHENYL-1,2,4-TRIAZOLE DERIVATIVE, CARBAMATE | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | disclosed |
| EP-0022531-A1 | 1-(2,4-Dichlorophenyl)-1-(2,6-dihalogenobenzylmercapto)-2-(1,2,4-triazol-1-yl)-ethanes, process for their preparation and their use as fungicides | BAYER AG (DE) | 1981-01-21 | — | — | EP | disclosed |
| EP-0000018-B1 | METAL SALT COMPLEXES OF 1-PHENYL-2-TRIAZOLYL-ETHANE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1981-01-07 | — | — | EP | disclosed |
| EP-0000017-A1 | 1-(2-Phenylethyl)-triazolium salts, their preparation and their use as fungicides | BAYER AG (DE) | 1978-12-20 | — | — | EP | disclosed |
| EP-0000018-A1 | Metal salt complexes of 1-phenyl-2-triazolyl-ethane derivatives, their preparation and their use as fungicides | BAYER AG (DE) | 1978-12-20 | — | — | EP | disclosed |
| US-4102891-A | FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040046-A1 | ITRACONAZOLE ANALOGS AND USE THEREOF | SHH, GLI1, KDR | ADRA2C 1400/4885KCNH2 4508/4885LMNA 4868/4885 |
| US-11028078-B2 | Itraconazole analogs and use thereof | SHH, GLI1, KDR | ADRA2C 1400/4885KCNH2 4508/4885LMNA 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.